Polskie Towarzystwo Farmacji Klinicznej - Polish Society of Clinical Pharmacy

What Polskie Towarzystwo Farmacji Klinicznej - Polish Society of Clinical Pharmacy does

Polskie Towarzystwo Farmacji Klinicznej (PTFK), the Polish Society of Clinical Pharmacy, is a registered non-profit professional association founded in 2020 and headquartered in Wrocław, Poland. It is the first and only professional society dedicated exclusively to clinical pharmacy in Poland, serving hospital and clinical pharmacists, pharmacy students, and primary healthcare pharmacists. The society operates through 14 specialist sections covering cardiology, gynecology-obstetrics, neonatology-pediatrics, hematology, infectious disease therapy, geriatrics, primary healthcare, intensive care, prehabilitation, clinical research, psychiatry, diabetology, nephrology, and therapeutic drug monitoring (TDM). PTFK's core products include the annual Sympozjum PTFK (250+ participants at the 2025 edition), Akademia PTFK educational workshops, Masterclass PTFK training programs (e.g., antibiotic stewardship), and authored clinical pharmacy tools such as the MILC-APIC pharmaceutical consultation form and the Standard of Medication Reconciliation (Koncyliacja Lekowa).

PTFK's revenue model is built on annual membership fees (90 PLN/year as of 2024, up from 50 PLN in 2023) supplemented by event registration fees (e.g., 150 PLN for non-members at Akademia PTFK) and project grants from the Polish Ministry of Education and Science under programs like 'Excellent Science II.' The go-to-market motion is community-led: membership recruitment occurs through the PTFK website, Facebook, and professional referrals, while demand generation relies on annual symposia, workshops, and webinars. The society engages in advocacy with the Ministry of Health and the Polish Senate, and conducts international collaboration through partnerships with the European Society of Clinical Pharmacy (ESCP), Medicines Optimisation Innovation Centre (MOIC, Northern Ireland), the Institute for Healthcare Improvement (USA), and other Polish medical associations. Strategic activities include a randomized multicenter study on integrated pharmacotherapy management now covering 18 Polish hospitals and 40+ pharmacists, a six-year Spanish internship program for Polish pharmacists, and a multi-party memorandum on oncological and hematological patient care signed with the Polish Pharmaceutical Society and the Polish Association of Oncology Pharmacists.

Name

Polskie Towarzystwo Farmacji Klinicznej - Polish Society of Clinical Pharmacy

Legal name

Polskie Towarzystwo Farmacji Klinicznej

Website

https://ptfk.pl

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

PTFK is a Polish non-profit professional society founded in 2020, serving hospital and clinical pharmacists across Poland through 14 specialist sections, annual symposia, workshops, and Masterclass training programs on clinical pharmacy practice and standards.

Ownership category

akta.pro rank

Product category

Professional Pharmacy Association Services

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro industry

PRIMARYHLAJAKAN

Global Health Research, Evidence & Technical Assistance Organizations

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)

SECONDARYHLAJAOAM

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

Keywords

• Clinical pharmacy education
• Medication reconciliation standards
• Professional pharmacist development
• Hospital pharmacy practice
• Pharmaceutical care training

Headquarters

HQ city

Wrocław

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: Annual membership dues provide primary recurring revenue. Members receive access to educational events, workshops, webinars, and the professional community.
2. Event Registration Fees: Revenue generated from paid symposium, workshop, and Masterclass registrations. Non-members pay higher fees; members receive discounted or free access to certain events.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Polskie Towarzystwo Farmacji Klinicznej operates a professional membership society that delivers continuing education, symposia, workshops, webinars, and specialist section activities to clinical and hospital pharmacists across Poland. The society also develops clinical pharmacy standards and tools (such as the medication reconciliation standard and MILC-APIC consultation form) and engages in policy advocacy with the Polish Ministry of Health and international bodies such as ESCP. Revenue is generated through annual membership dues and paid event registrations.

Differentiator

Problem solved

Functional benefit

Products and services

• PTFK Membership
• Sympozja PTFK (Annual Symposia)
• Akademia PTFK
• Masterclass PTFK - Antibiotic Therapy for Pharmacists (Basic Level)
• Sekcje Specjalistyczne PTFK (Specialist Sections)
• PTFK Standard of Medication Reconciliation (Koncyliacja lekowa)
• Formularz MILC-APIC

Quantifiable outcome

• 250+ participants at III Sympozjum PTFK 2025
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

14 partnerships are on record, tiered strategic, core and minor.

• Polish Diabetes Association (Polskie Stowarzyszenie Diabetyków)strategicStrategic or Co-development Partner · 15 April 2025Memorandum of cooperation signed between PTFK Diabetological Section and the Polish Diabetes Association. Aims to strengthen pharmacists' role in interdisciplinary care for type 2 diabetes patients through educational initiatives, training participation, mutual support, and joint projects.
• Medicines Optimisation Innovation Centre (MOIC) - Northern IrelandcoreStrategic or Co-development Partner · 30 August 2024International partnership with MOIC and Institute for Healthcare Improvement (USA) for the multicenter randomized study on integrated pharmacotherapy management in Poland. First conceptual work began in 2019, based on 6-year experience of Voivodeship Specialist Hospital in Wrocław.
• Polish Pharmaceutical Society (Polskie Towarzystwo Farmaceutyczne) - Oncological SectioncoreStrategic or Co-development Partner · 1 March 2024Joint agreement signed during the XII Congress of the Polish Association of Oncology Pharmacists in Toruń for collaborative action on behalf of oncological and hematological patients. Aims to improve quality and safety of pharmacotherapy for cancer patients.
• Polish Association of Oncology Pharmacists (PSFO)coreStrategic or Co-development Partner · 1 March 2024Signed joint memorandum with PTF Oncological Section and PSFO during XII Congress in Toruń for unified action to improve pharmacotherapy quality and safety for oncological and hematological patients.
• Institute of Pharmaceutical Care, Academy of Economics and Humanities in WarsawstrategicStrategic or Co-development Partner · 28 September 2023Co-organizer of the first PTFK Symposium 'Services of Clinical Pharmacy - New Quality in Healthcare' held in Warsaw in September 2023.
• European Society of Clinical Pharmacy (ESCP)coreStrategic or Co-development Partner · 28 July 2023PTFK entered into a memorandum with ESCP for joint action in clinical pharmacy. This partnership enables PTFK members to receive discounts on ESCP membership through the 'Combi membership PSCP-ESCP' option. The agreement facilitates international collaboration and knowledge exchange in clinical pharmacy practice.
• Minister of Education and Science (Minister Edukacji i Nauki)strategicOthersProject co-financed from state budget funds granted by the Minister of Education and Science under the 'Excellent Science II' program.
• Naczelna Izba Aptekarska (Polish Supreme Pharmaceutical Chamber)strategicStrategic or Co-development PartnerCooperation on pharmacist internship program in Spain; NACzelna Izba Aptekarska manages recruitment for the 6th edition of the professional internship program enabling Polish pharmacists to train in Spanish university hospital pharmacies.
• Stowarzyszenie Higieny Lecznictwa (Association of Hospital Hygiene)coreStrategic or Co-development PartnerPartnership in implementing the Masterclass PTFK - Antibiotic Therapy for Pharmacists program at basic level. Jointly organizes intensive practical workshops on clinical pharmacist's role in antibiotic therapy.
• Fresenius Kabi PolskaminorGTM or Marketing PartnerEducational partner for the Masterclass PTFK - Antibiotic Therapy for Pharmacists program. Provides support for educational activities on antibiotic stewardship.
• Śląska Izba Aptekarska (Silesian Chamber of Pharmacists)minorGTM or Marketing PartnerPatronage over the Masterclass PTFK - Antibiotic Therapy for Pharmacists program.
• Dolnośląska Izba Aptekarska (Lower Silesian Chamber of Pharmacists)minorGTM or Marketing PartnerPatronage over PTFK workshops held in Wrocław in October 2022. Participants received 4 hard educational points.
• Fundacja StomaLifeminorStrategic or Co-development PartnerEducational partner for the III PTFK Symposium 2025, providing a practical workshop for pharmacists on stoma care.
• Polish Society of Family Medicine (Polskie Towarzystwo Medycyny Rodzinnej)coreStrategic or Co-development PartnerCollaboration on medication review project in Primary Healthcare facilities under Coordinated Care. Aims to demonstrate benefits of medication reviews including reducing polypharmacy and improving safety and effectiveness of patient pharmacotherapy.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• American College of Clinical Pharmacy (ACCP): The largest US-based professional society for clinical pharmacists, offering certifications, journals (Pharmacotherapy), and educational programming. PTFK mirrors ACCP's mission of advancing clinical pharmacy as a distinct discipline through specialty sections and continuing education.
• Royal Pharmaceutical Society: The UK professional body for pharmacists, with which PTFK's board has working relationships (e.g., UCL-trained members). Comparable in providing standards, education, and advocacy, but with greater resources and statutory authority in the UK.
• European Society of Clinical Pharmacy (ESCP): The pan-European clinical pharmacy society with which PTFK holds a formal memorandum. ESCP operates across dozens of countries, runs larger international symposia, and sets cross-border standards — directly comparable in mission and offerings, but with vastly greater scale.
• EAHP (European Association of Hospital Pharmacists): The EU-wide association representing hospital pharmacists, with national member societies across Europe. Overlaps with PTFK's mission in advocating for hospital pharmacists' clinical roles and organizing educational events at a European level.
• Naczelna Izba Aptekarska (Polish Supreme Pharmaceutical Chamber): The statutory self-governing body for Polish pharmacists, overseeing licensure and professional standards. PTFK partners with NIA on the Spanish internship program; NIA is a regulatory peer with substantially larger reach and authority.

Direct peers

• Polskie Stowarzyszenie Farmaceutów Onkologicznych (PSFO - Polish Association of Oncology Pharmacists): A specialty Polish pharmacist society focused on oncology, with which PTFK has a joint memorandum. Directly comparable as a national pharmacist subspecialty society serving a defined clinical community through events and standards.
• Polskie Towarzystwo Farmaceutyczne (Polish Pharmaceutical Society): The umbrella Polish pharmaceutical scientific society, with which PTFK signed a joint memorandum for oncological/hematological patient work. Operates in the same national pharmacist community but focuses on broader pharmaceutical sciences, not exclusively clinical pharmacy.

Regional players

• Gesellschaft für klinische Pharmazie (German Society of Clinical Pharmacy): The German national society for clinical pharmacy, structurally identical to PTFK (membership-based, symposia, standards work). Operates in a larger healthcare system but does not directly compete since Germany is a separate market.
• Société Française de Pharmacie Clinique (French Society of Clinical Pharmacy): The French counterpart to PTFK — a national clinical pharmacy society running annual congresses, training programs, and clinical pharmacy standards. Direct functional parallel in another EU country.

Emerging players

• Medicines Optimisation Innovation Centre (MOIC): Northern Ireland-based innovation center focused on medicines optimization, partnered with PTFK on the multicenter pharmacotherapy study. Comparable as a research/education organization focused on clinical pharmacy services and polypharmacy reduction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Polskie-Towarzystwo-Farmacji-Klinicznej-107094500882428
• LinkedInlinkedin.com/company/polskie-towarzystwo-farmacji-klinicznej-polish-society-of-clinical-pharmacy

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Polskie Towarzystwo Farmacji Klinicznej - Polish Society of Clinical Pharmacy